We are live on !
Find out more
McIlrath & Eck Portfolio holdings
AUM
$1.35B
Turnover
47.68%
1-Year Est. Return
15.78%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+15.78%
3 Year Est. Return
+43.95%
5 Year Est. Return
+48.52%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$19.1M
(+10%)
Cap. Flow
+$8.01M
Cap. Flow % of AUM
Cap. Flow %
3.84%
Top 10 Holdings %
Top 10 Hldgs %
84.52%
Holding
684
New
34
Increased
115
Reduced
75
Closed
28
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.95M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.26M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$489K |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$462K |
| 5 |
PACCAR
PCAR
|
+$220K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$452K |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$242K |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$74.9K |
| 4 |
UMH Properties
UMH
|
+$52.6K |
| 5 |
Marathon Petroleum
MPC
|
+$51.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.86% |
| 2 | Technology | 11.12% |
| 3 | Financials | 2.19% |
| 4 | Communication Services | 1.63% |
| 5 | Consumer Discretionary | 1.59% |
Similar funds
McIlrath & Eck's Q4 2019 Portfolio in Review
As of Q4 2019, McIlrath & Eck held 684 positions worth $208M, up 10% from $189M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
McIlrath & Eck deployed $8.01M of net new capital in Q4 2019, opening 34 new positions and adding to 115 existing holdings. Its largest new stake was iShares Biotechnology ETF: 512 shares worth $62K.
By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, down from 81% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Morningstar Growth ETF, an estimated $452K trimmed.
- McIlrath & Eck's largest Q4 2019 buy was iShares Biotechnology ETF: 512 shares worth $62K.
- McIlrath & Eck added most to Microsoft in Q4 2019, an estimated $3.95M increase.
- McIlrath & Eck's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $452K.
- McIlrath & Eck fully exited Celgene Corp in Q4 2019, selling an estimated $48K.
- McIlrath & Eck's ten largest holdings make up 85% of its $208M portfolio in Q4 2019.
- McIlrath & Eck opened 34 new positions and closed 28 in Q4 2019.
- McIlrath & Eck's portfolio value rose 10% quarter-over-quarter to $208M.
Based on McIlrath & Eck's 13F filing for Q4 2019, filed 11 Feb 2020.